Needle-Free Drug Delivery Devices Market, Sector / Industry Report & Analysis, 2018-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Needle-Free Drug Delivery Devices Market


The global needle-free drug delivery devices market size was valued at USD 7.37 billion in 2017. It is poised to exhibit a CAGR of 10.5% during the forecast period. Widening base of diabetic patients and increasing ease in access to type1 diabetes are likely to stimulate the growth of the market during the forecast period.
Conventionally, Type 1 diabetes patients requiring regular glucose monitoring use needles, which increases the risk of infection and pain among individuals. Needle-free devices provide pain less delivery and negate the risk of infection. As a result, the demand for these devices is expected to increase during the forecast period.
 
Furthermore, surging demand and technological advancements in the field of pain-free drug transportation and self-administration have been playing an instrumental role in driving the market. For instance, Zogenix had introduced DosePro, a needle-free medication transportation technology in 2015, which is a prefilled, single-use. and disposable subcutaneous medicine transportation system for self-administration of liquid medicine formulations.
Rising pressure to curb the incidence rate of infectious diseases such as hepatitis, dengue fever, neurological disorders, and AIDS caused by West Nile virus during transmission is estimated to bode well for the growth of the market during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, about 47,352 individuals were diagnosed with HIV infection, of which 3,096 individuals were attributed to the injection drug use (IDU).

Market Segmentation, Outlook & Viewpoint: Global Needle-Free Drug Delivery Devices Market


Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Jet injectors

Inhaler technology

Transdermal patch technology

Novel needle-free technologies


Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

Vaccine delivery

Pain management

Insulin delivery for diabetes

Pediatric injections

Others


Key Players, Recent Developments & Regional Insights: Global Needle-Free Drug Delivery Devices Market


Insulin delivery was the most prominent application segment in the needle-free drug delivery device market in 2017.  The growh of the segment can be to rising incidence of diabetes and increasing shift towards unhealthy lifestyle habits. For instance, according to the Centers for Disease Control and Prevention, about 30.3 million individuals were affected by diabetes globally in 2017, of which 9.4% were U.S. citizens. However, about 23.1 million people were diagnosed and 7.2 million remained undiagnosed.
Moreover, owing to introduction of technologically advanced products such as insulin micropump, insulin pen, insulin spray, inhalable insulin, and other novel jet injectors, the insulin delivery segment is poised to post a lucrative CAGR during the forecast period. For instance, by 2019, Novartis is expected to launch an EpiPen that will cost around $250.0 and is cheaper than other EpiPen products available in the market. Additionally, Zeneno by Crossject is likely to be launched in the coming years and is estimated to have a lower target price.
 
In addition, the pain management segment held a sizeable share in the market owing to mounting cases of medical conditions such as chronic pain, pain disorder, myofascial pain syndrome, arthritis, and migraines. For instance, according to the American Pain Foundation Chronic in 2017, pain affected about 40-50 million Americans per year.

Regional Insights
North America accounted for approximately 44.0% of the overall revenue in 2017. High awareness regarding potential benefits of needle-free drug delivery devices has supported the dominance of the region in the global arena. Moreover, presence of well-developed healthcare facilities and extensive R&D expenditure by government organizations and pharmaceutical companies for diabetes and chronic pain management are also contributing to the growth of the market.
The Asia Pacific market is anticipated to witness lucrative growth over the forecast year owing to rising prevalence of diabetes in developing countries such as India and China. For instance, the International Diabetes Federation states that in 2017, India had about 7.2 billion individuals suffering from diabetes and China had about 11.4 billion individuals suffering from diabetes.
Needle-Free Drug Delivery Devices Market Share Insights
The needle-free drug delivery device market is marked by presence of various small and large companies. It is competitive in nature and dominated by key market players such as Antares Pharma, 3M, and Injex Pharma AG. Some other key players are Verdict Media Limited; Pharmajet; Zonenix; Inovio Pharmaceuticals, Inc.; Valeritas, Inc.; and Penjet.
Companies are adopting strategies such as new product launch, regional expansion, partnership, and distribution agreements to increase their market penetration. For instance, in October 2017, Antares Pharma and Ferring Pharmaceuticals entered into a definitive agreement. The latter received fixed assets from Antares and rights to sell ZOMAJET, needle-free auto-injector, worldwide. Additionally, in 2017, Takeda and Portal Instruments collaborated with each other to develop and commercialize Portal’s needle free drug delivery device, which is to be used with biologic medicines offered by Takeda Pharmaceuticals. Such initiatives are projected to propel the market during the forecast period. 

Key Insights Covered: Global Needle-Free Drug Delivery Devices Market
1.  North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Needle-Free Drug Delivery Devices industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Needle-Free Drug Delivery Devices industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Needle-Free Drug Delivery Devices industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Needle-Free Drug Delivery Devices industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Needle-Free Drug Delivery Devices industry.

Research Methodology: Global Needle-Free Drug Delivery Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other